“…Previous publications highlighted the issues of using 177 Lu from the 176 Lu(n,γ ) 177 Lu reaction, due to the production of the long lived impurity 177m Lu [14,19,20]. Several authors have reported the activity ratio between the activity of 177m Lu and the activity of 177 Lu in solution: A( 177m Lu)/A( 177 Lu)= 0.007% [11] A( 177m Lu)/A( 177 Lu)= 0.031% [15], A( 177m Lu)/A( 177 Lu)= 0.035% [17] and A( 177m Lu)/A( 177 Lu)= 0.02% [19].…”
Section: Discussionmentioning
confidence: 99%
“…It was found to be in agreement with the recommended value of 6.6463 (15) days (z-score = 1.8). [20].…”
Section: Discussionmentioning
confidence: 99%
“…Of these only the measurement reported by Dryak et al [18] has used 177 Lu from production method 2) and therefore not required corrections for the 177m Lu impurity. In a recent evaluation, Kellett [20] identified that the presence of 177m Lu has had a significant influence on the half-life determinations, while Pommé et al [14] observed that the omission of the impurity subtraction led to a 0.5% error in their determined halflife after only 7.6 days in their measurement campaign. A recent investigation at IFIN-HH [19] has highlighted the difficulty in determining an accurate activity ratio between the 177 Lu and 177m Lu.…”
Abstract. 177 Lu is a medium energy beta-emitter commonly used in Nuclear Medicine for radiotherapeutic applications. In this work, the half-life of 177 Lu has been measured using a re-entrant ionisation chamber over a period of 82 days (approximately 12 half-lives). Unlike the majority of previous studies, the material used in this work was produced via the 176 Yb(n,γ ) 177 Yb reaction followed by the β-decay to 177 Lu, producing insignificant quantities of 177m Lu. This has resulted in the most precise half-life measurement of 177 Lu to date. A half-life of 6.6430 (11) days has been determined. This value is in statistical agreement with the currently recommended half-life of 6.6463 (15) days (z-score = 1.8).
“…Previous publications highlighted the issues of using 177 Lu from the 176 Lu(n,γ ) 177 Lu reaction, due to the production of the long lived impurity 177m Lu [14,19,20]. Several authors have reported the activity ratio between the activity of 177m Lu and the activity of 177 Lu in solution: A( 177m Lu)/A( 177 Lu)= 0.007% [11] A( 177m Lu)/A( 177 Lu)= 0.031% [15], A( 177m Lu)/A( 177 Lu)= 0.035% [17] and A( 177m Lu)/A( 177 Lu)= 0.02% [19].…”
Section: Discussionmentioning
confidence: 99%
“…It was found to be in agreement with the recommended value of 6.6463 (15) days (z-score = 1.8). [20].…”
Section: Discussionmentioning
confidence: 99%
“…Of these only the measurement reported by Dryak et al [18] has used 177 Lu from production method 2) and therefore not required corrections for the 177m Lu impurity. In a recent evaluation, Kellett [20] identified that the presence of 177m Lu has had a significant influence on the half-life determinations, while Pommé et al [14] observed that the omission of the impurity subtraction led to a 0.5% error in their determined halflife after only 7.6 days in their measurement campaign. A recent investigation at IFIN-HH [19] has highlighted the difficulty in determining an accurate activity ratio between the 177 Lu and 177m Lu.…”
Abstract. 177 Lu is a medium energy beta-emitter commonly used in Nuclear Medicine for radiotherapeutic applications. In this work, the half-life of 177 Lu has been measured using a re-entrant ionisation chamber over a period of 82 days (approximately 12 half-lives). Unlike the majority of previous studies, the material used in this work was produced via the 176 Yb(n,γ ) 177 Yb reaction followed by the β-decay to 177 Lu, producing insignificant quantities of 177m Lu. This has resulted in the most precise half-life measurement of 177 Lu to date. A half-life of 6.6430 (11) days has been determined. This value is in statistical agreement with the currently recommended half-life of 6.6463 (15) days (z-score = 1.8).
Objective: To examine the impact of acquisition time on Lutetium-177 ( 177 Lu) singlephoton emission computed tomography (SPECT) images using Monte Carlo simulation.Methods: A gamma camera simulation based on the Monte Carlo method was performed to produce SPECT images. The phantom was modeled on a NEMA IEC BODY phantom including six spheres as tumors. After the administration of 7.4 GBq of 177 Lu, radioactivity concentrations of the tumor/liver at 6, 24, and 72 h after administration were set to 1.85/0.201, 2.12/0.156, and 1.95/0.117 MBq/mL, respectively. In addition, the radioactivity concentrations of the tumor at 72 h after administration varied by 1/2, 1/4, coefficient (CRC) and contrast-to-noise ratio (CNR). In this study, the CNR threshold for detectability was assumed to be 5.0.Results: To compare collimators, the highest sensitivity was observed with ELEGP, followed by LEHR and MEGP-1. The highest ratio of direct ray was also observed in ELEGP followed by MEGP-1. In comparison of the radioactivity concentration ratios of tumor/liver, CRC and CNR were significantly decreased with smaller radioactivity concentration ratios. This effect was greater with larger spheres. According to the visual assessment, the acquisition time of 6, 6, and 3 min or longer was required using ELEGP collimator at 6, 24, and 72 h after administration, respectively. Physical assessment based on CNR and CRC also suggested that 6, 6, and 3 min or longer acquisition time was necessary at 6, 24, and 72 h after administration.
Conclusion:177 Lu-SPECT images generated via the Monte Carlo simulation suggested that the recommended acquisition time was 6 min or longer at 6 and 24 h and 3 min or longer at 72 h after administration.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.